Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Effects of chlorogenic acid on adenine nucleotides hydrolyzing enzyme activities and expression in platelets of rats experimentally demyelinated with ethidium bromide.
Neurologic Diseases in Special Care Patients.
Gait characteristics according to pyramidal, sensory and cerebellar EDSS subcategories in people with multiple sclerosis.
Transcriptomic analyses of genes and tissues in inherited sensory neuropathies.
Symptomatic treatment in multiple sclerosis-interim analysis of a nationwide registry.
Metagenomic Analysis of Cerebrospinal Fluid from Patients with Multiple Sclerosis.
Sulthiame as monotherapy in children with benign childhood epilepsy with centrotemporal spikes: a 6-month randomized, double-blind, placebo-controlled study. Sulthiame Study Group.
Assessing the Value of Treatment to Address Various Symptoms Associated with Multiple Sclerosis: Results from a Contingent Valuation Study.
Phenotypic changes in the brain of SIV-infected macaques exposed to methamphetamine parallel macrophage activation patterns induced by the common gamma-chain cytokine system.
Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells, amplifying Th17 responses and autoimmunity.
Intravenous Immunoglobulin Therapy in a Patient With Anti-Myelin Oligodendrocyte Glycoprotein-Seropositive Neuromyelitis Optica.
Microglia-induced activation of non-canonical Wnt signaling aggravates neurodegeneration in demyelinating disorders.
Melatonin reverses H-89 induced spatial memory deficit: Involvement of oxidative stress and mitochondrial function.
Rhabdomyolysis following interferon-beta treatment in a patient with multiple sclerosis - A case report.
Evaluation of magnetic resonance imaging abnormalities in juvenile onset neuropsychiatric systemic lupus erythematosus.
Acute axonal damage in three different murine models of multiple sclerosis: a comparative approach.
Electrophysiologic features of fibular neuropathy in childhood and adolescence.
Oligodendrocyte differentiation.
Is physical exercise a multiple sclerosis disease modifying treatment?
General control non-derepressible 2 (GCN2) in T cells controls disease progression of autoimmune neuroinflammation.
Immune Parameters That Distinguish Multiple Sclerosis Patients from Patients with Other Neurological Disorders at Presentation.
Cyclic AMP is a key regulator of M1 to M2a phenotypic conversion of microglia in the presence of Th2 cytokines.
Genetic modifications associated with ketogenic diet treatment in the BTBR(T+Tf/J) mouse model of autism spectrum disorder.
Protective Effects on Central Nervous System by Acidic Polysaccharide of Panax ginseng in Relapse-Remitting Experimental Autoimmune Encephalomyelitis-Induced SJL/J Mice.
Persistency, medication prescribing patterns, and medical resource use associated with multiple sclerosis patients receiving oral disease-modifying therapies: a retrospective medical record review.

Pages